{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T10:41:46Z","timestamp":1791110506656,"version":"4.1.0"},"reference-count":149,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,6,6]]},"DOI":"10.3109\/10673229.2011.586550","type":"journal-article","created":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T14:02:25Z","timestamp":1306936945000},"page":"125-143","source":"Crossref","is-referenced-by-count":26,"title":["Glucocorticoids as Predictors of Treatment Response in Depression"],"prefix":"10.1097","volume":"19","author":[{"given":"Sonja","family":"Horstmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth B.","family":"Binder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-4-20210129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1196\/annals.1296.001","article-title":"Hormones and the stressed brain.","volume":"1018","author":"De Kloet","year":"2004","journal-title":"Ann N Y Acad Sci"},{"key":"R3-4-20210129","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0166-2236(96)10069-2","article-title":"Neurocircuitry of stress: central control of the hypothalamo-pituitary-adrenocortical axis.","volume":"20","author":"Herman","year":"1997","journal-title":"Trends Neurosci"},{"key":"R4-4-20210129","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1210\/endo-117-6-2505","article-title":"Two receptor systems for corticosterone in rat brain: microdistribution and differential occupation.","volume":"117","author":"Reul","year":"1985","journal-title":"Endocrinology"},{"key":"R5-4-20210129","first-page":"269","article-title":"Brain corticosteroid receptor balance in health and disease.","volume":"19","author":"De Kloet","year":"1998","journal-title":"Endocr Rev"},{"key":"R6-4-20210129","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.yfrne.2003.07.001","article-title":"Central mechanisms of stress integration: hierarchical circuitry controlling hypothalamo-pituitary-adrenocortical responsiveness.","volume":"24","author":"Herman","year":"2003","journal-title":"Front Neuroendocrinol"},{"key":"R7-4-20210129","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/0896-6273(94)90431-6","article-title":"Heterodimerization between mineralocorticoid and glucocorticoid receptor: a new principle of glucocorticoid action in the CNS.","volume":"13","author":"Trapp","year":"1994","journal-title":"Neuron"},{"key":"R8-4-20210129","first-page":"306","article-title":"Steroid receptor interactions with heat shock protein and immunophilin chaperones.","volume":"18","author":"Pratt","year":"1997","journal-title":"Endocr Rev"},{"issue":"172","key":"R9-4-20210129","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/3-540-29717-0_5","article-title":"Chaperoning of glucocorticoid receptors.","author":"Pratt","year":"2006","journal-title":"Handb Exp Pharmacol"},{"key":"R10-4-20210129","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.bbamcr.2009.11.012","article-title":"Molecular chaperones, essential partners of steroid hormone receptors for activity and mobility.","volume":"1803","author":"Echeverria","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"R11-4-20210129","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1038\/sj.npp.1300257","article-title":"ABCB1 (MDR1)-type P-glycoproteins at the blood-brain barrier modulate the activity of the hypothalamic-pituitary-adrenocortical system: implications for affective disorder.","volume":"28","author":"Muller","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"R12-4-20210129","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1046\/j.1365-2826.2002.00836.x","article-title":"Penetration of endogenous steroid hormones corticosterone, cortisol, aldosterone and progesterone into the brain is enhanced in mice deficient for both mdr1a and mdr1b P-glycoproteins.","volume":"14","author":"Uhr","year":"2002","journal-title":"J Neuroendocrinol"},{"key":"R13-4-20210129","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.neuron.2007.11.017","article-title":"Polymorphisms in the drug transporter gene ABCB1 predict antidepressant treatment response in depression.","volume":"57","author":"Uhr","year":"2008","journal-title":"Neuron"},{"key":"R14-4-20210129","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0006-3223(03)00177-X","article-title":"Mood disorders and allostatic load.","volume":"54","author":"McEwen","year":"2003","journal-title":"Biol Psychiatry"},{"key":"R15-4-20210129","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S0006-3223(01)01157-X","article-title":"The role of childhood trauma in the neurobiology of mood and anxiety disorders: preclinical and clinical studies.","volume":"49","author":"Heim","year":"2001","journal-title":"Biol Psychiatry"},{"key":"R16-4-20210129","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0893-133X(00)00159-7","article-title":"The corticosteroid receptor hypothesis of depression.","volume":"23","author":"Holsboer","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"R17-4-20210129","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nrn1683","article-title":"Stress and the brain: from adaptation to disease.","volume":"6","author":"de Kloet","year":"2005","journal-title":"Nat Rev Neurosci"},{"key":"R18-4-20210129","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1176\/appi.ajp.160.9.1554","article-title":"When not enough is too much: the role of insufficient glucocorticoid signaling in the pathophysiology of stress-related disorders.","volume":"160","author":"Raison","year":"2003","journal-title":"Am J Psychiatry"},{"key":"R19-4-20210129","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1126\/science.6334362","article-title":"Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients.","volume":"226","author":"Nemeroff","year":"1984","journal-title":"Science"},{"key":"R20-4-20210129","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1001\/archpsyc.1988.01800300075009","article-title":"Reduced corticotropin releasing factor binding sites in the frontal cortex of suicide victims.","volume":"45","author":"Nemeroff","year":"1988","journal-title":"Arch Gen Psychiatry"},{"key":"R21-4-20210129","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1523\/JNEUROSCI.4734-03.2004","article-title":"Dysregulation in the suicide brain: mRNA expression of corticotropin-releasing hormone receptors and GABA(A) receptor subunits in frontal cortical brain region.","volume":"24","author":"Merali","year":"2004","journal-title":"J Neurosci"},{"key":"R22-4-20210129","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1159\/000126778","article-title":"Increased numbers of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients.","volume":"60","author":"Raadsheer","year":"1994","journal-title":"Neuroendocrinology"},{"key":"R23-4-20210129","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1001\/archpsyc.1996.01830020055007","article-title":"Increased number of vasopressin- and oxytocin-expressing neurons in the paraventricular nucleus of the hypothalamus in depression.","volume":"53","author":"Purba","year":"1996","journal-title":"Arch Gen Psychiatry"},{"key":"R24-4-20210129","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1210\/jcem-61-3-429","article-title":"The 24-hour profile of adrenocorticotropin and cortisol in major depressive illness.","volume":"61","author":"Linkowski","year":"1985","journal-title":"J Clin Endocrinol Metab"},{"key":"R25-4-20210129","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1210\/jcem-65-5-962","article-title":"Pulsatile rhythms of adrenocorticotropin (ACTH) and cortisol in women with endogenous depression: evidence for increased ACTH pulse frequency.","volume":"65","author":"Mortola","year":"1987","journal-title":"J Clin Endocrinol Metab"},{"key":"R26-4-20210129","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1001\/archpsyc.1987.01800160032006","article-title":"Neuroendocrine aspects of primary endogenous depression. I. Cortisol secretory dynamics in patients and matched controls.","volume":"44","author":"Rubin","year":"1987","journal-title":"Arch Gen Psychiatry"},{"key":"R27-4-20210129","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/00002826-198303000-00002","article-title":"The dexamethasone suppression test in depression.","volume":"6","author":"Green","year":"1983","journal-title":"Clin Neuropharmacol"},{"key":"R28-4-20210129","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1001\/archpsyc.1992.01820050048008","article-title":"Adrenal gland enlargement in major depression. A computed tomographic study.","volume":"49","author":"Nemeroff","year":"1992","journal-title":"Arch Gen Psychiatry"},{"key":"R29-4-20210129","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0165-1781(92)90070-J","article-title":"In vivo assessment of pituitary volume with magnetic resonance imaging and systematic stereology: relationship to dexamethasone suppression test results in patients.","volume":"44","author":"Axelson","year":"1992","journal-title":"Psychiatry Res"},{"key":"R30-4-20210129","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0165-0327(82)90039-8","article-title":"Repeated dexamethasone suppression test during depressive illness. Normalisation of test result compared with clinical improvement.","volume":"4","author":"Holsboer","year":"1982","journal-title":"J Affect Disord"},{"key":"R31-4-20210129","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1176\/ajp.154.11.1497","article-title":"DST studies in psychotic depression: a meta-analysis.","volume":"154","author":"Nelson","year":"1997","journal-title":"Am J Psychiatry"},{"key":"R32-4-20210129","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0306-4530(85)90038-1","article-title":"Plasma corticosterone and cortisol following dexamethasone in psychiatric patients.","volume":"10","author":"Arana","year":"1985","journal-title":"Psychoneuroendocrinology"},{"key":"R33-4-20210129","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1056\/NEJM198410253111718","article-title":"Blunted corticotropin and normal cortisol response to human corticotropin-releasing factor in depression.","volume":"311","author":"Holsboer","year":"1984","journal-title":"N Engl J Med"},{"key":"R34-4-20210129","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0165-0327(88)90037-7","article-title":"The oCRH stimulation test before and after clinical recovery from depression.","volume":"14","author":"Amsterdam","year":"1988","journal-title":"J Affect Disord"},{"key":"R35-4-20210129","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1176\/ajp.141.5.619","article-title":"Psychiatric implications of basic and clinical studies with corticotropin-releasing factor.","volume":"141","author":"Gold","year":"1984","journal-title":"Am J Psychiatry"},{"key":"R36-4-20210129","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/0022-3956(94)90017-5","article-title":"The combined dexamethasoneCRH test: a refined laboratory test for psychiatric disorders.","volume":"28","author":"Heuser","year":"1994","journal-title":"J Psychiatr Res"},{"key":"R37-4-20210129","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/0006-3223(87)90237-X","article-title":"Serial assessment of corticotropin-releasing hormone response after dexamethasone in depression. Implications for pathophysiology of DST nonsuppression.","volume":"22","author":"Holsboer","year":"1987","journal-title":"Biol Psychiatry"},{"key":"R38-4-20210129","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.pnpbp.2005.03.014","article-title":"The combined dexamethasoneCRH test as a potential surrogate marker in depression.","volume":"29","author":"Ising","year":"2005","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"R39-4-20210129","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.psyneuen.2006.03.001","article-title":"The dexCRH testis it better than the DST P","volume":"31","author":"Watson","year":"2006","journal-title":"sychoneuroendocrinology"},{"key":"R41-4-20210129","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.biopsych.2007.07.002","article-title":"The dexamethasonecorticotropin-releasing factor test in men with major depression: role of childhood trauma.","volume":"63","author":"Heim","year":"2008","journal-title":"Biol Psychiatry"},{"key":"R42-4-20210129","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1210\/edrv-17-2-187","article-title":"Antidepressants and hypothalamic-pituitary-adrenocortical regulation.","volume":"17","author":"Holsboer","year":"1996","journal-title":"Endocr Rev"},{"key":"R43-4-20210129","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S0196-9781(01)00398-9","article-title":"Hyperactivity of CRH neuronal circuits as a target for therapeutic interventions in affective disorders.","volume":"22","author":"Keck","year":"2001","journal-title":"Peptides"},{"key":"R44-4-20210129","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/0024-3205(85)90480-1","article-title":"Combined administration of human corticotropin-releasing factor and lysine vasopressin induces cortisol escape from dexamethasone suppression in healthy subjects.","volume":"37","author":"von Bardeleben","year":"1985","journal-title":"Life Sci"},{"key":"R45-4-20210129","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1038\/sj.npp.1300280","article-title":"Pharmacological and nonpharmacological factors influencing hypothalamic-pituitary-adrenocortical axis reactivity in acutely depressed psychiatric in-patients, measured by the Dex-CRH test.","volume":"28","author":"Kunzel","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"R46-4-20210129","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0022-3956(01)00010-3","article-title":"Psychological, autonomic and neuroendocrine responses to acute stressors in the combined dexamethasoneCRH test: a study in healthy subjects.","volume":"35","author":"Oshima","year":"2001","journal-title":"J Psychiatr Res"},{"key":"R47-4-20210129","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0022-3956(01)00013-9","article-title":"Cortisol response in the combined dexamethasoneCRH test as predictor of relapse in patients with remitted depression. A prospective study.","volume":"35","author":"Zobel","year":"2001","journal-title":"J Psychiatr Res"},{"key":"R48-4-20210129","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/0006-3223(88)90202-8","article-title":"Exaggerated corticotrophic cell response to human corticotropin-releasing hormone in two patients during long-term carbamazepine treatment.","volume":"24","author":"von Bardeleben","year":"1988","journal-title":"Biol Psychiatry"},{"key":"R49-4-20210129","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/da.10078","article-title":"Lithium augmentation increases post-dexamethasone cortisol in the dexamethasone suppression test in unipolar major depression.","volume":"17","author":"Bschor","year":"2003","journal-title":"Depress Anxiety"},{"key":"R50-4-20210129","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S1474-4422(03)00409-5","article-title":"Clinically important drug interactions in epilepsy: general features and interactions between antiepileptic drugs.","volume":"2","author":"Patsalos","year":"2003","journal-title":"Lancet Neurol"},{"key":"R51-4-20210129","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1177\/070674378903400514","article-title":"The effect of anticonvulsants on the dexamethasone suppression test.","volume":"34","author":"Keitner","year":"1989","journal-title":"Can J Psychiatry"},{"key":"R52-4-20210129","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0022-3956(99)00014-X","article-title":"The dexamethasone corticotropin-releasing hormone test in depression in bipolar and unipolar affective illness.","volume":"33","author":"Rybakowski","year":"1999","journal-title":"J Psychiatr Res"},{"key":"R53-4-20210129","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1038\/sj.npp.1301168","article-title":"Regulation of the hypothalamic-pituitary-adrenocortical system in patients with panic disorder.","volume":"31","author":"Erhardt","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"R54-4-20210129","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0893-133X(95)00146-5","article-title":"Dysregulation of the hypothalamic-pituitary-adrenocortical system in panic disorder.","volume":"15","author":"Schreiber","year":"1996","journal-title":"Neuropsychopharmacology"},{"key":"R55-4-20210129","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/0006-3223(95)00064-X","article-title":"Combined dexamethasonecorticotropin-releasing hormone test in acute and remitted manic patients, in acute depression, and in normal controls: I.","volume":"38","author":"Schmider","year":"1995","journal-title":"Biol Psychiatry"},{"key":"R56-4-20210129","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/0006-3223(95)00065-8","article-title":"Combined dexamethasonecorticotropin-releasing hormone test in patients with schizophrenia and in normal controls: II.","volume":"38","author":"Lammers","year":"1995","journal-title":"Biol Psychiatry"},{"key":"R57-4-20210129","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1210\/jcem.86.4.7416","article-title":"Combined treatment with corticosteroids and moclobemide favors normalization of hypothalamo-pituitary-adrenal axis dysregulation in relapsing-remitting multiple sclerosis: a randomized, double blind trial.","volume":"86","author":"Then Bergh","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"R58-4-20210129","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1001\/archpsyc.1985.01790350067012","article-title":"The dexamethasone suppression test for diagnosis and prognosis in psychiatry. Commentary and review.","volume":"42","author":"Arana","year":"1985","journal-title":"Arch Gen Psychiatry"},{"key":"R59-4-20210129","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0197-4580(94)90117-1","article-title":"Age-associated changes of pituitary-adrenocortical hormone regulation in humans: importance of gender.","volume":"15","author":"Heuser","year":"1994","journal-title":"Neurobiol Aging"},{"key":"R60-4-20210129","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1038\/nn943","article-title":"Treatment of mood disorders.","volume":"5 suppl","author":"Nemeroff","year":"2002","journal-title":"Nat Neurosci"},{"key":"R61-4-20210129","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1210\/endo.133.1.8391426","article-title":"Chronic treatment of rats with the antidepressant amitriptyline attenuates the activity of the hypothalamic-pituitary-adrenocortical system.","volume":"133","author":"Reul","year":"1993","journal-title":"Endocrinology"},{"key":"R62-4-20210129","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1159\/000126788","article-title":"Hypothalamic-pituitary-adrenocortical axis changes in the rat after long-term treatment with the reversible monoamine oxidase-A inhibitor moclobemide.","volume":"60","author":"Reul","year":"1994","journal-title":"Neuroendocrinology"},{"key":"R63-4-20210129","first-page":"336","article-title":"The corticotropin-releasing factor (CRF) hypothesis of depression: new findings and new directions.","volume":"1","author":"Nemeroff","year":"1996","journal-title":"Mol Psychiatry"},{"key":"R64-4-20210129","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1001\/archpsyc.1983.01790050019002","article-title":"Dexamethasone suppression tests in antidepressant treatment of melancholia. The process of normalization and test-retest reproducibility.","volume":"40","author":"Greden","year":"1983","journal-title":"Arch Gen Psychiatry"},{"key":"R65-4-20210129","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1176\/ajp.150.11.1618","article-title":"The DST as a predictor of outcome in depression: a meta-analysis.","volume":"150","author":"Ribeiro","year":"1993","journal-title":"Am J Psychiatry"},{"key":"R66-4-20210129","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1176\/ajp.141.2.247","article-title":"Correlation between the dexamethasone suppression test in depressed patients and clinical response.","volume":"141","author":"Nemeroff","year":"1984","journal-title":"Am J Psychiatry"},{"key":"R67-4-20210129","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1210\/jcem.82.1.3689","article-title":"Diurnal activity and pulsatility of the hypothalamus-pituitary-adrenal system in male depressed patients and healthy controls.","volume":"82","author":"Deuschle","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"R68-4-20210129","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1055\/s-2003-38087","article-title":"Clinical outcome after trimipramine in patients with delusional depressiona pilot study.","volume":"36","author":"Frieboes","year":"2003","journal-title":"Pharmacopsychiatry"},{"key":"R69-4-20210129","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1176\/ajp.153.1.93","article-title":"Pituitary-adrenal-system regulation and psychopathology during amitriptyline treatment in elderly depressed patients and normal comparison subjects.","volume":"153","author":"Heuser","year":"1996","journal-title":"Am J Psychiatry"},{"key":"R70-4-20210129","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0165-1781(91)90041-M","article-title":"Repeated administration of the combined dexamethasone-human corticotropin releasing hormone stimulation test during treatment of depression.","volume":"38","author":"Holsboer-Trachsler","year":"1991","journal-title":"Psychiatry Res"},{"key":"R71-4-20210129","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/0022-3956(94)90020-5","article-title":"Sleep deprivation and bright light as potential augmenters of antidepressant drug treatmentneurobiological and psychometric assessment of course.","volume":"28","author":"Holsboer-Trachsler","year":"1994","journal-title":"J Psychiatr Res"},{"key":"R72-4-20210129","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/00004714-200304000-00008","article-title":"Clinical and neurobiological effects of tianeptine and paroxetine in major depression.","volume":"23","author":"Nickel","year":"2003","journal-title":"J Clin Psychopharmacol"},{"key":"R73-4-20210129","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/sj.npp.1300003","article-title":"Fluvoxamine reduces responsiveness of HPA axis in adult female BPD patients with a history of sustained childhood abuse.","volume":"28","author":"Rinne","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"R74-4-20210129","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s00213-006-0382-7","article-title":"Time course of hypothalamic-pituitary-adrenocortical axis activity during treatment with reboxetine and mirtazapine in depressed patients.","volume":"186","author":"Schule","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"key":"R75-4-20210129","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s00213-002-1356-z","article-title":"Attenuation of hypothalamic-pituitary-adrenocortical hyperactivity in depressed patients by mirtazapine.","volume":"166","author":"Schule","year":"2003","journal-title":"Psychopharmacology (Berl)"},{"key":"R76-4-20210129","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.psyneuen.2008.09.004","article-title":"Suppressive effect of mirtazapine on the HPA system in acutely depressed women seems to be transient and not related to antidepressant action.","volume":"34","author":"Horstmann","year":"2009","journal-title":"Psychoneuroendocrinology"},{"key":"R77-4-20210129","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/sj.npp.1300868","article-title":"Assessment of the dexamethasoneCRH test as a state-dependent marker for hypothalamic-pituitary-adrenal (HPA) axis abnormalities in major depressive episode: a multicenter study.","volume":"31","author":"Kunugi","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"R78-4-20210129","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1600-0447.2005.00625.x","article-title":"HPA axis normalization, estimated by DEXCRH test, but less alteration on cerebral glucose metabolism in depressed patients receiving ECT after medication treatment failures.","volume":"112","author":"Yuuki","year":"2005","journal-title":"Acta Psychiatr Scand"},{"key":"R79-4-20210129","first-page":"551","article-title":"Changes in serial dexamethasone suppression tests among unipolar depressive receiving electroconvulsive treatment.","volume":"16","author":"Albala","year":"1981","journal-title":"Biol Psychiatry"},{"key":"R80-4-20210129","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/S0306-4530(02)00029-X","article-title":"The combined dexamethasone-CRH test before and after repetitive transcranial magnetic stimulation (rTMS) in major depression.","volume":"28","author":"Zwanzger","year":"2003","journal-title":"Psychoneuroendocrinology"},{"key":"R81-4-20210129","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jpsychires.2008.05.002","article-title":"Clinical characteristics and treatment outcome in a representative sample of depressed inpatientsfindings from the Munich Antidepressant Response Signature (MARS) project.","volume":"43","author":"Hennings","year":"2009","journal-title":"J Psychiatr Res"},{"key":"R82-4-20210129","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000068873","article-title":"Influence of mirtazapine on salivary cortisol in depressed patients.","volume":"47","author":"Laakmann","year":"2003","journal-title":"Neuropsychobiology"},{"key":"R83-4-20210129","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.psyneuen.2008.08.018","article-title":"HPA-axis regulation at in-patient admission is associated with antidepressant therapy outcome in male but not in female depressed patients.","volume":"34","author":"Binder","year":"2009","journal-title":"Psychoneuroendocrinology"},{"key":"RU84-4-20210129","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/00004714-199706000-00003","article-title":"Pulse-dosing and conventional application of doxepin: effects on psychopathology and hypothalamus-pituitary-adrenal (HPA) system.","volume":"17","author":"Deuschle","year":"1997","journal-title":"J Clin Psychopharmacol"},{"key":"RU85-4-20210129","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0022-3956(02)00021-3","article-title":"The combined DEX-CRH test in treatment course and long-term outcome of major depression.","volume":"36","author":"Hatzinger","year":"2002","journal-title":"J Psychiatr Res"},{"key":"RU86-4-20210129","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0022-3956(02)00088-2","article-title":"Association between response to lithium augmentation and the combined DEXCRH test in major depressive disorder.","volume":"37","author":"Bschor","year":"2003","journal-title":"J Psychiatr Res"},{"key":"R87-4-20210129","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s00213-005-0034-3","article-title":"Long-term citalopram administration reduces responsiveness of HPA axis in patients with major depression: relationship with S-citalopram concentrations in plasma and cerebrospinal fluid (CSF) and clinical response.","volume":"181","author":"Nikisch","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"key":"R89-4-20210129","first-page":"47","article-title":"Combined dexamethasonecorticotropin releasing hormone test predicts treatment response in major depressiona potential biomarker Biol P","volume":"62","author":"Ising","year":"2007","journal-title":"sychiatry"},{"key":"R90-4-20210129","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.jpsychires.2006.07.007","article-title":"The dexCRH neuroendocrine test and the prediction of depressive relapse in remitted depressed outpatients.","volume":"41","author":"Aubry","year":"2007","journal-title":"J Psychiatr Res"},{"key":"RU91-4-20210129","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.biopsych.2006.03.075","article-title":"Successful antidepressant therapy restores the disturbed interplay between TNF-alpha system and HPA axis.","volume":"60","author":"Himmerich","year":"2006","journal-title":"Biol Psychiatry"},{"key":"RU92-4-20210129","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.jpsychires.2010.04.010","article-title":"A single dexCRH test in male drug-free depressed patients is associated with the clinical response to treatment with fluoxetine.","volume":"44","author":"Paslakis","year":"2010","journal-title":"J Psychiatr Res"},{"key":"R94-4-20210129","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0193-953X(05)70283-5","article-title":"Definition and epidemiology of treatment-resistant depression.","volume":"19","author":"Fava","year":"1996","journal-title":"Psychiatr Clin North Am"},{"key":"R95-4-20210129","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1176\/appi.ajp.163.1.28","article-title":"Evaluation of outcomes with citalopram for depression using measurement-based care in STARD: implications for clinical practice.","volume":"163","author":"Trivedi","year":"2006","journal-title":"Am J Psychiatry"},{"key":"R96-4-20210129","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1056\/NEJMoa052963","article-title":"Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression.","volume":"354","author":"Rush","year":"2006","journal-title":"N Engl J Med"},{"key":"R97-4-20210129","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1056\/NEJMoa052964","article-title":"Medication augmentation after the failure of SSRIs for depression.","volume":"354","author":"Trivedi","year":"2006","journal-title":"N Engl J Med"},{"key":"R98-4-20210129","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1176\/ajp.2006.163.7.1161","article-title":"A comparison of mirtazapine and nortriptyline following two consecutive failed medication treatments for depressed outpatients: a STARD report.","volume":"163","author":"Fava","year":"2006","journal-title":"Am J Psychiatry"},{"key":"R99-4-20210129","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1176\/ajp.156.6.949","article-title":"Prediction of medium-term outcome by cortisol response to the combined dexamethasone-CRH test in patients with remitted depression.","volume":"156","author":"Zobel","year":"1999","journal-title":"Am J Psychiatry"},{"key":"R100-4-20210129","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.biopsych.2005.09.008","article-title":"Glucocorticoids and relapse of major depression (dexamethasonecorticotropin-releasing hormone test in relation to relapse of major depression).","volume":"59","author":"Appelhof","year":"2006","journal-title":"Biol Psychiatry"},{"key":"R101-4-20210129","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.psyneuen.2008.03.008","article-title":"The link between childhood trauma and depression: insights from HPA axis studies in humans.","volume":"33","author":"Heim","year":"2008","journal-title":"Psychoneuroendocrinology"},{"key":"R102-4-20210129","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.biopsych.2008.01.011","article-title":"Childhood parental loss and adult hypothalamic-pituitary-adrenal function.","volume":"63","author":"Tyrka","year":"2008","journal-title":"Biol Psychiatry"},{"key":"R103-4-20210129","doi-asserted-by":"crossref","first-page":"14293","DOI":"10.1073\/pnas.2336126100","article-title":"Differential responses to psychotherapy versus pharmacotherapy in patients with chronic forms of major depression and childhood trauma.","volume":"100","author":"Nemeroff","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"R104-4-20210129","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1001\/archgenpsychiatry.2007.26","article-title":"Influence of child abuse on adult depression: moderation by the corticotropin-releasing hormone receptor gene.","volume":"65","author":"Bradley","year":"2008","journal-title":"Arch Gen Psychiatry"},{"key":"R105-4-20210129","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1001\/archgenpsychiatry.2009.114","article-title":"Protective effect of CRHR1 gene variants on the development of adult depression following childhood maltreatment: replication and extension.","volume":"66","author":"Polanczyk","year":"2009","journal-title":"Arch Gen Psychiatry"},{"key":"R108-4-20210129","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.biopsych.2009.05.012","article-title":"Interaction of childhood maltreatment with the corticotropin-releasing hormone receptor gene: effects on hypothalamic-pituitary-adrenal axis reactivity.","volume":"66","author":"Tyrka","year":"2009","journal-title":"Biol Psychiatry"},{"key":"R109-4-20210129","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3389\/neuro.08.041.2009","article-title":"Effect of childhood trauma on adult depression and neuroendocrine function: sex-specific moderation by CRG receptor 1 gene.","volume":"3","author":"Heim","year":"2009","journal-title":"Front Behav Neurosci"},{"key":"R110-4-20210129","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.psyneuen.2009.03.017","article-title":"Gene-environment interactions predict cortisol responses after acute stress: implications for the etiology of depression.","volume":"34","author":"Alexander","year":"2009","journal-title":"Psychoneuroendocrinology"},{"key":"R112-4-20210129","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.biopsych.2003.12.008","article-title":"Rearing condition and rh5-HTTLPR interact to influence limbic-hypothalamic-pituitary-adrenal axis response to stress in infant macaques.","volume":"55","author":"Barr","year":"2004","journal-title":"Biol Psychiatry"},{"key":"R113-4-20210129","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.yhbeh.2009.01.009","article-title":"Serotonin transporter gene variation, infant abuse, and responsiveness to stress in rhesus macaque mothers and infants.","volume":"55","author":"McCormack","year":"2009","journal-title":"Horm Behav"},{"key":"R114-4-20210129","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1176\/appi.ajp.2008.07071199","article-title":"A 6-week randomized, placebo-controlled trial of CP-316,311 (a selective CRH1 antagonist) in the treatment of major depression.","volume":"165","author":"Binneman","year":"2008","journal-title":"Am J Psychiatry"},{"key":"R115-4-20210129","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1038\/sj.npp.1301328","article-title":"High-affinity CRF1 receptor antagonist NBI-34041: preclinical and clinical data suggest safety and efficacy in attenuating elevated stress response.","volume":"32","author":"Ising","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"R117-4-20210129","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1097\/00004714-200110000-00009","article-title":"Rapid reversal of psychotic depression using mifepristone.","volume":"21","author":"Belanoff","year":"2001","journal-title":"J Clin Psychopharmacol"},{"key":"R118-4-20210129","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/S0006-3223(02)01432-4","article-title":"An open label trial of C-1073 (mifepristone) for psychotic major depression.","volume":"52","author":"Belanoff","year":"2002","journal-title":"Biol Psychiatry"},{"key":"R119-4-20210129","doi-asserted-by":"crossref","first-page":"598","DOI":"10.4088\/JCP.v66n0509","article-title":"An 8-week open-label trial of a 6-day course of mifepristone for the treatment of psychotic depression.","volume":"66","author":"Simpson","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"R120-4-20210129","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/j.biopsych.2006.05.034","article-title":"Mifepristone versus placebo in the treatment of psychosis in patients with psychotic major depression.","volume":"60","author":"DeBattista","year":"2006","journal-title":"Biol Psychiatry"},{"key":"R121-4-20210129","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/sj.npp.1300884","article-title":"Clinical and biological effects of mifepristone treatment for psychotic depression.","volume":"31","author":"Flores","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"R122-4-20210129","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.cct.2009.03.001","article-title":"A multisite trial of mifepristone for the treatment of psychotic depression: a site-by-treatment interaction.","volume":"30","author":"Blasey","year":"2009","journal-title":"Contemp Clin Trials"},{"key":"R123-4-20210129","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0165-1781(87)90006-0","article-title":"Psychotic and nonpsychotic depressions: I. Comparison of plasma catecholamines and cortisol measures.","volume":"20","author":"Rothschild","year":"1987","journal-title":"Psychiatry Res"},{"key":"R124-4-20210129","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/j.1749-6632.1988.tb42128.x","article-title":"The roles of glucocorticoid and dopaminergic systems in delusional (psychotic) depression.","volume":"537","author":"Schatzberg","year":"1988","journal-title":"Ann N Y Acad Sci"},{"key":"R125-4-20210129","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1001\/archpsyc.57.8.755","article-title":"24-hour monitoring of cortisol and corticotropin secretion in psychotic and nonpsychotic major depression.","volume":"57","author":"Posener","year":"2000","journal-title":"Arch Gen Psychiatry"},{"key":"R126-4-20210129","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.biopsych.2005.10.014","article-title":"Cortisol circadian rhythm alterations in psychotic major depression.","volume":"60","author":"Keller","year":"2006","journal-title":"Biol Psychiatry"},{"key":"R127-4-20210129","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1038\/ng1479","article-title":"Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment.","volume":"36","author":"Binder","year":"2004","journal-title":"Nat Genet"},{"key":"R128-4-20210129","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1001\/archgenpsychiatry.2010.18","article-title":"Association of polymorphisms in genes regulating the corticotropin-releasing factor system with antidepressant treatment response.","volume":"67","author":"Binder","year":"2010","journal-title":"Arch Gen Psychiatry"},{"key":"R129-4-20210129","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jad.2007.02.017","article-title":"Genetic variability at HPA axis in major depression and clinical response to antidepressant treatment.","volume":"104","author":"Papiol","year":"2007","journal-title":"J Affect Disord"},{"key":"R130-4-20210129","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1038\/sj.mp.4001587","article-title":"Association of a corticotropin-releasing hormone receptor 1 haplotype and antidepressant treatment response in Mexican-Americans.","volume":"9","author":"Licinio","year":"2004","journal-title":"Mol Psychiatry"},{"key":"R131-4-20210129","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.neulet.2006.12.013","article-title":"Association study of corticotropin-releasing hormone receptor1 gene polymorphisms and antidepressant response in major depressive disorders.","volume":"414","author":"Liu","year":"2007","journal-title":"Neurosci Lett"},{"key":"R132-4-20210129","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1176\/appi.ajp.2009.09070932","article-title":"Genome-wide pharmacogenetics of antidepressant response in the GENDEP project.","volume":"167","author":"Uher","year":"2010","journal-title":"Am J Psychiatry"},{"key":"R133-4-20210129","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.biopsych.2006.02.007","article-title":"Polymorphisms of the glucocorticoid receptor gene and major depression.","volume":"59","author":"van Rossum","year":"2006","journal-title":"Biol Psychiatry"},{"key":"R134-4-20210129","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.psyneuen.2006.08.001","article-title":"Prediction of treatment response by HPA-axis and glucocorticoid receptor polymorphisms in major depression.","volume":"31","author":"Brouwer","year":"2006","journal-title":"Psychoneuroendocrinology"},{"key":"R135-4-20210129","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/tpj.2009.12","article-title":"Genetic predictors of response to antidepressants in the GENDEP project.","volume":"9","author":"Uher","year":"2009","journal-title":"Pharmacogenomics J"},{"key":"R137-4-20210129","doi-asserted-by":"crossref","first-page":"841","DOI":"10.2217\/14622416.9.7.841","article-title":"Genetic variants in FKBP5 affecting response to antidepressant drug treatment.","volume":"9","author":"Kirchheiner","year":"2008","journal-title":"Pharmacogenomics"},{"key":"R138-4-20210129","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1002\/ajmg.b.30246","article-title":"Lack of supporting evidence for a genetic association of the FKBP5 polymorphism and response to antidepressant treatment.","volume":"144","author":"Tsai","year":"2007","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"RU139-4-20210129","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.biopsych.2008.10.002","article-title":"Variation in catechol-O-methyltransferase is associated with duloxetine response in a clinical trial for major depressive disorder.","volume":"65","author":"Perlis","year":"2009","journal-title":"Biol Psychiatry"},{"key":"R140-4-20210129","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0960-0760(02)00062-6","article-title":"Glucocorticoid receptor variants: clinical implications.","volume":"81","author":"DeRijk","year":"2002","journal-title":"J Steroid Biochem Mol Biol"},{"key":"R141-4-20210129","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.ejphar.2008.03.012","article-title":"Corticosteroid receptor-gene variants: modulators of the stress-response and implications for mental health.","volume":"585","author":"Derijk","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"R142-4-20210129","doi-asserted-by":"crossref","first-page":"3128","DOI":"10.2337\/diabetes.51.10.3128","article-title":"A polymorphism in the glucocorticoid receptor gene, which decreases sensitivity to glucocorticoids in vivo, is associated with low insulin and cholesterol levels.","volume":"51","author":"van Rossum","year":"2002","journal-title":"Diabetes"},{"key":"R143-4-20210129","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/sj.npp.1300898","article-title":"Glucocorticoid receptor gene-based SNP analysis in patients with recurrent major depression.","volume":"31","author":"van West","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"R144-4-20210129","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/ajmg.b.30886","article-title":"Glucocorticoid receptor gene polymorphisms and childhood adversity are associated with depression: new evidence for a gene-environment interaction.","volume":"150B","author":"Bet","year":"2009","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"R145-4-20210129","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.biopsych.2009.08.029","article-title":"A genomewide association study of citalopram response in major depressive disorder.","volume":"67","author":"Garriock","year":"2010","journal-title":"Biol Psychiatry"},{"key":"R146-4-20210129","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1001\/archgenpsychiatry.2009.95","article-title":"A genome-wide association study points to multiple loci predicting treatment outcome in depression.","volume":"66","author":"Ising","year":"2009","journal-title":"Arch Gen Psychiatry"},{"key":"R147-4-20210129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-5793(01)02326-2","article-title":"Receptor accessory folding helper enzymes: the functional role of peptidyl prolyl cistrans isomerases.","volume":"495","author":"Schiene-Fischer","year":"2001","journal-title":"FEBS Lett"},{"key":"R148-4-20210129","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1021\/bi048503v","article-title":"Differential control of glucocorticoid receptor hormone-binding function by tetratricopeptide repeat (TPR) proteins and the immunosuppressive ligand FK506.","volume":"44","author":"Davies","year":"2005","journal-title":"Biochemistry"},{"key":"R149-4-20210129","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.biopsych.2008.10.002","article-title":"Variation in catechol-O-methyltransferase is associated with duloxetine response in a clinical trial for major depressive disorder.","volume":"65","author":"Perlis","year":"2009","journal-title":"Biol Psychiatry"},{"key":"R153-4-20210129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/jama.299.11.1291","article-title":"Association of FKBP5 polymorphisms and childhood abuse with risk of posttraumatic stress disorder symptoms in adults.","volume":"299","author":"Binder","year":"2008","journal-title":"JAMA"},{"key":"R156-4-20210129","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1460-9568.2008.06332.x","article-title":"Polymorphisms in the FKBP5 gene region modulate recovery from psychosocial stress in healthy controls.","volume":"28","author":"Ising","year":"2008","journal-title":"Eur J Neurosci"},{"key":"R157-4-20210129","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/mp.2009.141","article-title":"The CRF system, stress, depression and anxiety-insights from human genetic studies.","volume":"15","author":"Binder","year":"2010","journal-title":"Mol Psychiatry"},{"key":"R158-4-20210129","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/mp.2009.92","article-title":"Sequence variations of ABCB1, SLC6A2, SLC6A3, SLC6A4, CREB1, CRHR1 and NTRK2: association with major depression and antidepressant response in Mexican-Americans.","volume":"14","author":"Dong","year":"2009","journal-title":"Mol Psychiatry"},{"key":"R160-4-20210129","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1001\/archgenpsychiatry.2010.18","article-title":"Association of polymorphisms in genes regulating the corticotropin-releasing factor system with antidepressant treatment response.","volume":"67","author":"Binder","year":"2010","journal-title":"Arch Gen Psychiatry"},{"key":"R162-4-20210129","first-page":"638","article-title":"How can we realize the promise of personalized antidepressant medicines Nat Rev N","volume":"9","author":"Holsboer","year":"2008","journal-title":"eurosci"},{"key":"R163-4-20210129","first-page":"454","article-title":"Genome-wide gene-expression profiles following glucocorticoid stimulation associated with major depression.","volume":"67","author":"Menke","year":"2010","journal-title":"Biol Psychiatry"},{"key":"R164-4-20210129","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.biopsych.2004.02.010","article-title":"Enhanced sensitivity to glucocorticoids in peripheral mononuclear leukocytes in posttraumatic stress disorder.","volume":"55","author":"Yehuda","year":"2004","journal-title":"Biol Psychiatry"},{"key":"R165-4-20210129","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jad.2009.05.016","article-title":"Stress hormones in patients with posttraumatic stress disorder caused by myocardial infarction and role of comorbid depression.","volume":"121","author":"von Kanel","year":"2009","journal-title":"J Affect Disord"}],"container-title":["Harvard Review of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.3109\/10673229.2011.586550","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,17]],"date-time":"2021-06-17T19:28:02Z","timestamp":1623958082000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00023727-201106060-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6,6]]},"references-count":149,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.3109\/10673229.2011.586550","relation":{},"ISSN":["1067-3229"],"issn-type":[{"value":"1067-3229","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6,6]]}}}